| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 4e-10 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.07 |